Issue 7, 2024

Mercaptopyrimidine-templated gold nanoclusters for antithrombotic therapy

Abstract

Here we report for the first time that mercaptopyrimidine-templated gold nanoclusters (DAMP-AuNCs) can be used as a novel anticoagulant candidate for the design of antithrombotic drugs. Anticoagulant mechanisms revealed that DAMP-AuNCs significantly inhibited thrombus formation by interacting with fibrinogen. Carrageenan-induced mice tail thrombosis model experiments showed that DAMP-AuNCs had antithrombotic efficacy comparable to heparin in vivo. More importantly, these ultrasmall AuNCs possess excellent blood compatibility and only induce negligible bleeding side effects. Our study is a successful attempt at developing novel antithrombotic agents with high biosafety.

Graphical abstract: Mercaptopyrimidine-templated gold nanoclusters for antithrombotic therapy

Supplementary files

Article information

Article type
Communication
Submitted
08 Nov 2023
Accepted
23 Jan 2024
First published
25 Jan 2024

J. Mater. Chem. B, 2024,12, 1775-1781

Mercaptopyrimidine-templated gold nanoclusters for antithrombotic therapy

J. Dai, J. Lei, T. Zhang, J. You, D. Qin, Y. Wu, Y. Liu and Y. Zheng, J. Mater. Chem. B, 2024, 12, 1775 DOI: 10.1039/D3TB02652C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements